Associated Papers
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
Herencia-Ropero A et al.
Genome Medicine, 2024
39187844 (PubMed )
Supplement: 13073_2024_1370_MOESM3_ESM.xlsx › SNV
APOE and vascular disease: Sequencing and genotyping in general population cohorts.
Rasmussen KL et al.
Atherosclerosis, 2023
Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration.
Rasmussen KL et al.
Jama Ophthalmology, 2023
APOE and dementia - resequencing and genotyping in 105,597 individuals.
Rasmussen KL et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2020
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.
Zhou Y et al.
Journal of Lipid Research, 2018
30076208 (PubMed )
Supplement: 10.1194_P086710_jlr.P086710-4.xlsx › APOE
Select a paper to view details